Lenvatinib Administered via Nasogastric Tube in Poorly Differentiated Thyroid Cancer

BACKGROUND: The tyrosine kinase inhibitors (TKIs) are indicated for the treatment of locally advanced or metastatic progressive thyroid carcinoma (CDT), refractory to radioactive iodine. The following report describes the efficacy of lenvatinib administered through a nose-gastric tube (SNG) in a pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Molinaro, Eleonora, Viola, David, Viola, Nicola, Falcetta, Pierpaolo, Orsolini, Francesca, Torregrossa, Liborio, Vagli, Paola, Ribechini, Alessandro, Materazzi, Gabriele, Vitti, Paolo, Elisei, Rossella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766666/
https://www.ncbi.nlm.nih.gov/pubmed/31641541
http://dx.doi.org/10.1155/2019/6831237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766666/
https://www.ncbi.nlm.nih.gov/pubmed/31641541
http://dx.doi.org/10.1155/2019/6831237

Ejemplares similares